174 related articles for article (PubMed ID: 30077190)
1. A synthetic mitochondrial-based vector for therapeutic purposes.
Renteln M
Med Hypotheses; 2018 Aug; 117():28-30. PubMed ID: 30077190
[TBL] [Abstract][Full Text] [Related]
2. [MITO-Porter; a cutting-edge technology for mitochondrial gene therapy].
Furukawa R; Yamada Y; Harashima H
Yakugaku Zasshi; 2012; 132(12):1389-98. PubMed ID: 23208046
[TBL] [Abstract][Full Text] [Related]
3. An analysis of membrane fusion between mitochondrial double membranes and MITO-Porter, mitochondrial fusogenic vesicles.
Yamada Y; Fukuda Y; Harashima H
Mitochondrion; 2015 Sep; 24():50-5. PubMed ID: 26188112
[TBL] [Abstract][Full Text] [Related]
4. Dual function MITO-Porter, a nano carrier integrating both efficient cytoplasmic delivery and mitochondrial macromolecule delivery.
Yamada Y; Furukawa R; Yasuzaki Y; Harashima H
Mol Ther; 2011 Aug; 19(8):1449-56. PubMed ID: 21694702
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial transgene expression via an artificial mitochondrial DNA vector in cells from a patient with a mitochondrial disease.
Ishikawa T; Somiya K; Munechika R; Harashima H; Yamada Y
J Control Release; 2018 Mar; 274():109-117. PubMed ID: 29408532
[TBL] [Abstract][Full Text] [Related]
6. Multifaceted roles of porin in mitochondrial protein and lipid transport.
Endo T; Sakaue H
Biochem Soc Trans; 2019 Oct; 47(5):1269-1277. PubMed ID: 31670371
[TBL] [Abstract][Full Text] [Related]
7. Delivery of bioactive molecules to the mitochondrial genome using a membrane-fusing, liposome-based carrier, DF-MITO-Porter.
Yamada Y; Harashima H
Biomaterials; 2012 Feb; 33(5):1589-95. PubMed ID: 22105068
[TBL] [Abstract][Full Text] [Related]
8. [Development of the MITO-porter, a nano device for mitochondrial drug delivery via membrane fusion].
Yamada Y
Yakugaku Zasshi; 2014; 134(11):1143-55. PubMed ID: 25366911
[TBL] [Abstract][Full Text] [Related]
9. Insertion of proteins into the inner membrane of mitochondria: the role of the Oxa1 complex.
Stuart R
Biochim Biophys Acta; 2002 Sep; 1592(1):79-87. PubMed ID: 12191770
[TBL] [Abstract][Full Text] [Related]
10. Role of MINOS in mitochondrial membrane architecture: cristae morphology and outer membrane interactions differentially depend on mitofilin domains.
Zerbes RM; Bohnert M; Stroud DA; von der Malsburg K; Kram A; Oeljeklaus S; Warscheid B; Becker T; Wiedemann N; Veenhuis M; van der Klei IJ; Pfanner N; van der Laan M
J Mol Biol; 2012 Sep; 422(2):183-91. PubMed ID: 22575891
[TBL] [Abstract][Full Text] [Related]
11. Targeting the mitochondrial genome via a dual function MITO-Porter: evaluation of mtDNA levels and mitochondrial function.
Yamada Y; Harashima H
Methods Mol Biol; 2015; 1265():123-33. PubMed ID: 25634272
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial matrix delivery using MITO-Porter, a liposome-based carrier that specifies fusion with mitochondrial membranes.
Yasuzaki Y; Yamada Y; Harashima H
Biochem Biophys Res Commun; 2010 Jun; 397(2):181-6. PubMed ID: 20580633
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Mmp37p, a Saccharomyces cerevisiae mitochondrial matrix protein with a role in mitochondrial protein import.
Gallas MR; Dienhart MK; Stuart RA; Long RM
Mol Biol Cell; 2006 Sep; 17(9):4051-62. PubMed ID: 16790493
[TBL] [Abstract][Full Text] [Related]
14. The membrane insertase Oxa1 is required for efficient import of carrier proteins into mitochondria.
Hildenbeutel M; Theis M; Geier M; Haferkamp I; Neuhaus HE; Herrmann JM; Ott M
J Mol Biol; 2012 Nov; 423(4):590-9. PubMed ID: 22846909
[TBL] [Abstract][Full Text] [Related]
15. The mitochondrial oxidase assembly protein1 (Oxa1) insertase forms a membrane pore in lipid bilayers.
Krüger V; Deckers M; Hildenbeutel M; van der Laan M; Hellmers M; Dreker C; Preuss M; Herrmann JM; Rehling P; Wagner R; Meinecke M
J Biol Chem; 2012 Sep; 287(40):33314-26. PubMed ID: 22829595
[TBL] [Abstract][Full Text] [Related]
16. Packaging of the Coenzyme Q
Yamada Y; Burger L; Kawamura E; Harashima H
Biol Pharm Bull; 2017; 40(12):2183-2190. PubMed ID: 29199241
[TBL] [Abstract][Full Text] [Related]
17. MITO-Porter for Mitochondrial Delivery and Mitochondrial Functional Analysis.
Yamada Y; Harashima H
Handb Exp Pharmacol; 2017; 240():457-472. PubMed ID: 27830347
[TBL] [Abstract][Full Text] [Related]
18. Targeting the Mitochondrial Genome Via a MITO-Porter : Evaluation of mtDNA and mtRNA Levels and Mitochondrial Function.
Yamada Y; Harashima H
Methods Mol Biol; 2021; 2275():227-245. PubMed ID: 34118041
[TBL] [Abstract][Full Text] [Related]
19. Preprotein transport machineries of yeast mitochondrial outer membrane are not required for Bax-induced release of intermembrane space proteins.
Sanjuán Szklarz LK; Kozjak-Pavlovic V; Vögtle FN; Chacinska A; Milenkovic D; Vogel S; Dürr M; Westermann B; Guiard B; Martinou JC; Borner C; Pfanner N; Meisinger C
J Mol Biol; 2007 Apr; 368(1):44-54. PubMed ID: 17335847
[TBL] [Abstract][Full Text] [Related]
20. Validation of a mitochondrial RNA therapeutic strategy using fibroblasts from a Leigh syndrome patient with a mutation in the mitochondrial ND3 gene.
Yamada Y; Somiya K; Miyauchi A; Osaka H; Harashima H
Sci Rep; 2020 May; 10(1):7511. PubMed ID: 32371897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
